Bristol-Myers to Buy Turning Point Therapeutics for $4.1 Billion
Bristol-Myers Squibb Co. said it will acquire biotechnology company Turning Point Therapeutics Inc. TPTX 116.76% for $4.1 billion, an effort...
Bristol-Myers Squibb Co. said it will acquire biotechnology company Turning Point Therapeutics Inc. TPTX 116.76% for $4.1 billion, an effort...
The Food and Drug Administration has denied a petition by short sellers to halt clinical trials of an experimental Alzheimer’s...
Biogen Inc. is selling its share in biosimilar joint venture Samsung Bioepis for at least $2.25 billion to partner Samsung...
The Centers for Disease Control and Prevention recommended Covid-19 boosters for 12- to 15-year-olds, making the doses available to the...
LONDON— AstraZeneca PLC’s Covid-19 vaccine isn’t authorized in the U.S., and governments in Canada, Australia and across Western Europe have...
Human blood samples and the substance that makes fireflies glow are among the tools that scientists are using for early...
A Covid-19 antibody treatment developed by GlaxoSmithKline PLC and Vir Biotechnology Inc. was effective against the Omicron variant in early...
The Food and Drug Administration on Friday cleared Covid-19 boosters from Pfizer Inc. and BioNTech SE and from Moderna Inc....
Pfizer Inc. said it asked U.S. health regulators to authorize its oral Covid-19 drug for use in high-risk patients, putting...
Pfizer Inc. raised its forecast for sales of its Covid-19 vaccine this year to about $36 billion, a roughly 7%...
The Food and Drug Administration said the Covid-19 vaccine from Pfizer Inc. PFE 0.70% and BioNTech SE BNTX -2.80% met...
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...